bioAffinity Technologies, Inc. announced on June 11, 2025, that its President and CEO, Maria Zannes, has been appointed to the American Lung Association in Texas’ Leadership Board. This board comprises healthcare professionals and advocates dedicated to advancing lung health.
In this role, Ms. Zannes will contribute her expertise to support the Lung Association’s mission, which includes preventing lung disease and promoting lung health through research, education, and advocacy. Her appointment is expected to raise bioAffinity Technologies' profile within the community.
This position allows Ms. Zannes to advocate for lung health and increase resources for local programs and services, aligning with bioAffinity Technologies' focus on noninvasive diagnostics for lung cancer and other lung diseases like asthma and COPD.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.